Radiosurgery Systems (Neurology Devices) Market Future Insights and Forecast Projections 2030

Data Bridge Market Research analyses that the global radiosurgery systems (neurology devices) market was USD 1,798.68 million in 2022, is expected to reach USD 2,722.19 million by 2030, and is expected to undergo a CAGR of 5.11% during the forecast period of 2023 to 2030. “

Press Release Apr 21, 2025 31 Add to Reading List

The Radiosurgery Systems (Neurology Devices) Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2030. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-radiosurgery-systems-neurology-devices-market

Which are the top companies operating in the Radiosurgery Systems (Neurology Devices) Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Radiosurgery Systems (Neurology Devices) Market report provides the information of the Top Companies in Radiosurgery Systems (Neurology Devices) Market in the market their business strategy, financial situation etc.

Abbott (U.S.), Johnson & Johnson Services, Inc. (U.S.), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Medtronic (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), MicroPort Scientific Corporation (China), Merit Medical Systems (U.S.), W.L. Gore & Associates, Inc. (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), UreSil, LLC (U.S.), Medikit co., ltd. (Japan), Bayer AG (Germany), Acandis GmbH (Germany), Biosensors International Group, Ltd. (Singapore), Integra LifeSciences Corporation (U.S.), Elekta (Sweden), C.R. Bard, Inc. (U.S.)

Report Scope and Market Segmentation

Which are the driving factors of the Radiosurgery Systems (Neurology Devices) Market?

The driving factors of the Radiosurgery Systems (Neurology Devices) Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Radiosurgery Systems (Neurology Devices) Market - Competitive and Segmentation Analysis:

**Segments**

- On the basis of product type, the radiosurgery systems (neurology devices) market can be segmented into gamma-ray based systems, linear accelerator (LINAC) based systems, and proton beam therapy systems. Gamma-ray based systems are expected to dominate the market due to their efficacy in targeting specific areas of the brain with high precision. LINAC based systems are also witnessing significant growth as they offer flexibility in delivering radiation therapy for a wide range of neurological conditions. Proton beam therapy systems are gaining traction for their ability to minimize damage to surrounding healthy tissue.

- By application, the market can be categorized into brain tumor treatment, arteriovenous malformations (AVMs), trigeminal neuralgia, movement disorders, and others. Brain tumor treatment holds the largest share in the market as radiosurgery systems provide a non-invasive option for treating both malignant and benign brain tumors. The rise in the prevalence of AVMs and trigeminal neuralgia is driving the demand for radiosurgery systems in treating these conditions. Moreover, the adoption of radiosurgery systems for movement disorders such as Parkinson's disease is also on the rise.

- Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, and cancer research institutes. Hospitals account for the majority of the market share due to the high patient inflow for neurological procedures. Ambulatory surgical centers are gaining popularity as they offer cost-effective treatment options for patients requiring radiosurgery procedures. Cancer research institutes play a crucial role in driving technological advancements and clinical research in the field of radiosurgery systems.

**Market Players**

- Some of the key players in the global radiosurgery systems (neurology devices) market include Accuray Incorporated, Elekta AB, Varian Medical Systems, Inc., Brainlab AG, Nordion (Canada) Inc., Ion Beam Applications SA, Hokai, GammaStar, Radionics, Inc., and Mitsubishi Electric Corporation. These companies are focusing on strategic collaborations, productThe global radiosurgery systems (neurology devices) market is witnessing robust growth and is characterized by several key segments that drive its expansion. In terms of product type segmentation, the market is divided into gamma-ray based systems, LINAC based systems, and proton beam therapy systems. Gamma-ray based systems are anticipated to lead the market due to their precision in targeting specific brain areas. LINAC based systems are also experiencing significant growth owing to their flexibility in delivering radiation therapy for various neurological conditions. Proton beam therapy systems are gaining traction for their ability to minimize damage to surrounding healthy tissue, providing a promising alternative for patients.

Moving on to the application segment, the market can be categorized into brain tumor treatment, arteriovenous malformations (AVMs), trigeminal neuralgia, movement disorders, and others. Brain tumor treatment dominates the market share as radiosurgery systems offer a non-invasive treatment option for both malignant and benign brain tumors. The increasing prevalence of AVMs and trigeminal neuralgia is fueling the demand for radiosurgery systems in addressing these conditions. Additionally, there is a growing adoption of radiosurgery systems for movement disorders such as Parkinson's disease, bolstering market growth further.

Furthermore, when considering the end-user segmentation of the market, it is divided into hospitals, ambulatory surgical centers, and cancer research institutes. Hospitals hold the largest share in the market due to the high volume of patients undergoing neurological procedures. Ambulatory surgical centers are gaining popularity as they provide cost-effective treatment options for patients requiring radiosurgery procedures. Cancer research institutes play a crucial role in advancing technology and conducting clinical research in the field of radiosurgery systems, thus contributing significantly to market development.

In terms of market players, key companies shaping the global radiosurgery systems (neurology devices) market include Accuray Incorporated, Elekta AB, Varian Medical Systems, Inc., Brainlab AG, Nordion (Canada) Inc., Ion Beam Applications SA, Hokai, GammaStar**Market Players:**
- Abbott (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Stryker Corporation (U.S.)
- Medtronic (Ireland)
- Terumo Corporation (Japan)
- Penumbra, Inc. (U.S.)
- MicroPort Scientific Corporation (China)
- Merit Medical Systems (U.S.)
- W.L. Gore & Associates, Inc. (U.S.)
- B. Braun Melsungen AG (Germany)
- Cook (U.S.)
- UreSil, LLC (U.S.)
- Medikit co., ltd. (Japan)
- Bayer AG (Germany)
- Acandis GmbH (Germany)
- Biosensors International Group, Ltd. (Singapore)
- Integra LifeSciences Corporation (U.S.)
- Elekta (Sweden)
- C.R. Bard, Inc. (U.S.)

The global radiosurgery systems (neurology devices) market is experiencing significant growth driven by key segments that play a crucial role in its expansion. The product type segmentation includes gamma-ray based systems, LINAC based systems, and proton beam therapy systems. Gamma-ray based systems are poised to lead the market by offering precise targeting of specific brain areas. LINAC based systems are also on the rise due to their flexibility in delivering radiation therapy for various neurological conditions, while proton beam therapy systems are gaining traction for their ability to minimize damage to surrounding healthy tissue, providing

Explore Further Details about This Research Radiosurgery Systems (Neurology Devices) Market Report https://www.databridgemarketresearch.com/reports/global-radiosurgery-systems-neurology-devices-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Radiosurgery Systems (Neurology Devices) Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Radiosurgery Systems (Neurology Devices) Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Radiosurgery Systems (Neurology Devices) Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2030) of the following regions are covered in Chapters

The countries covered in the Radiosurgery Systems (Neurology Devices) Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Radiosurgery Systems (Neurology Devices) Market Insights and Forecast to 2030

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Radiosurgery Systems (Neurology Devices) Market Landscape

Part 05: Pipeline Analysis

Part 06: Radiosurgery Systems (Neurology Devices) Market Sizing

Part 07: Five Forces Analysis

Part 08: Radiosurgery Systems (Neurology Devices) Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Radiosurgery Systems (Neurology Devices) Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com